Breast Screening Articles & Analysis
33 news found
Among other milestones in this remarkable year: Forming a new supervisory board whose members include internationally recognised breast radiologist Dr Rachel Brem and Allyson White, Principal at Insight Partners. ...
InHealth, who provide services for North and East Devon NHS Breast Screening, has entered into the research agreement to work with Kheiron Medical Technologies as part of the AI in Health & Care Award. This partnership marks another significant step in the journey to build an evidence base to demonstrate the effectiveness and safety of artificial intelligence ...
QView Medical is pleased to announce FDA approval for QVCAD to be used with the GE Invenia™ ABUS in breast screening for asymptomatic dense breasted women whose mammogram was negative. ...
The Transpara AI breast care solution, now being used in over 30 countries worldwide to find breast cancers faster and earlier, has 'remarkable potential' to reduce Radiologists' workload, according to a leading research team in Spain. ...
Komen®Stand for H.E.R—a Health Equity Revolution program by bringing point-of-care breast health resources to patients and healthcare providers in U.S. metropolitan areas where breast cancer mortality gaps are greatest between Black and white women. ...
Elizabeth Morris, and Dr. Amy Patel to its US Breast Medical Advisory Board. These appointments reinforce Kheiron’s focus on bringing its artificial intelligence solutions to the US market to help radiologists detect breast cancer earlier. Kheiron is committed to assembling an inclusive advisory board that shares its mission for creating equitable access to ...
The team running the country's largest breast screening programme have shown that using Transpara breast AI further confirmed the enormous contribution of this technology to breast cancer detection: not only to reduce the number of false positives but also to reduce radiologists' workload by over 60%. In Copenhagen, the biannual ...
In a recent study, the Registry used over 120,000 screening examinations from a population-based program to assess potential of using AI in screening and came up with some surprising answers. ...
But the numbers are destined to grow, since the pandemic has caused significant delays in screening and, on average, a 37.6% reduction in mammography scans [Source: Gisma: Mammography screening after the pandemic] It is therefore essential to have valid alternatives to make up for the delay in the prevention and early diagnosis of the most common diseases, ...
Kheiron has pioneered the development and deployment of artificial intelligence solutions to help radiologists detect breast cancer earlier, and the company is currently leveraging its existing technologies and expertise to expand into new cancer types. ...
He has been instrumental in launching and scaling many industry-first technologies including the first Computer Aided Detection algorithm for the early detection of breast cancer, the first mammography analytics platform and a multi-point risk stratified breast screening scorecard. ...
It is known that overall, up to 25% of breast cancers are missed by screening and considered detectable in retrospect. ...
The company recently finished their first Republic crowdfunding campaign, exceeding capital targets, and raising over $2.6M in only 5 months. Koning's FDA breast screening trial is also underway with participating clinics in Daytona Beach, FL and Knoxville, TN. ...
The manuscript, published in Lymphatic Research and Biology, concluded “[L-Dex] screening should be a standard approach for prospective breast cancer-related lymphedema surveillance” and is available online here: https://www.liebertpub.com/doi/10.1089/lrb.2021.0084. ...
With an unbiased assessment for every unscreened woman, RSViP generates an actionable list that the breast screening scheduler can use to book appointments for women who may be most at risk of developing breast cancer. ...
Invenia ABUS 2.0 is the first FDA-approved Ultrasound supplemental breast screening technology specifically designed for detecting cancer in dense breast tissue. ...
Notably, at the CureMetrix corporate symposium on Tuesday, November 30, at 1:30 pm CT, Kevin Harris, president and co-founder of CureMetrix, will present, “Extending the Value of Radiology from Breast Health to Women’s Health.” At this enlightening session, Mr. Harris will review innovative AI decision support tools, and share new, national research that shows ...
Aidoc’s inclusion of a full breast imaging AI solution with mammography and tomosynthesis is a natural next step in the company’s radiology practice-wide offering. ...
ByAidoc
(Seno) has launched its CONFIDENCE registry to evaluate the efficacy of imaging with opto-acoustic/ultrasound (OA/US) to diagnose breast abnormalities including cancer using its groundbreaking Imagio® Breast Imaging System. ...
“The Polish healthcare system is known for providing advanced cancer treatment and adopting new therapies and technologies. As breast cancer continues to be one of the most common types of cancer among Polish women, with a reported 24,644 women diagnosed in 20201, Poland has joined the global effort to increase breast cancer screening in ...